» Articles » PMID: 10508131

Multicenter Evaluation of Tosoh Glycohemoglobin Analyzer

Overview
Journal Clin Chem
Specialty Biochemistry
Date 1999 Oct 3
PMID 10508131
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We describe an Anglo-French evaluation of a new analyzer.

Methods: The Tosoh HLC-723 GHb V, A1c2.2 glycohemoglobin analyzer is an HPLC instrument with primary blood tube sampling, bar-code reading, cap piercing, and the ability to chromatographically separate labile hemoglobin A1c (HbA1c). We evaluated two analytical protocols, 2.2 and 3.0 min, and compared results for blood samples collected from diabetic and nondiabetic subjects with those obtained with Bio-Rad Diamat and Variant analyzers.

Results: Within- and between batch-imprecision (CVs) was <2% with linearity to at least 15.9% HbA1c. Although some hemoglobinopathies were detected in the 2. 2-min chromatography, clearer evidence of abnormality was visible in the 3.0-min version. Comparison with established methods showed good correlation (r = 0.993; n = 316 with Diamat; and r = 0.995; n = 133 with Variant) but highlighted calibration differences.

Conclusions: The problems of manual blood sample preparation, labile HbA1c, and carbamylated hemoglobin interference associated with the older instruments have been eliminated in the new Tosoh analyzer. The 3. 0-min protocol is preferred for routine use.

Citing Articles

Development and Validation of a Simple Risk Model for Predicting Metabolic Syndrome (MetS) in Midlife: A Cohort Study.

Ibrahim M, Pang D, Randhawa G, Pappas Y Diabetes Metab Syndr Obes. 2022; 15:1051-1075.

PMID: 35418767 PMC: 8995775. DOI: 10.2147/DMSO.S336384.


Life-Course Influence of Adolescent Behaviour Problems on Type 2 Diabetes in Midlife: Results from 1958 British Birth Cohort Study.

Saad S, Iwundu C, Ibrahim M, Randhawa G, Pang D Diabetes Metab Syndr Obes. 2022; 15:963-972.

PMID: 35378832 PMC: 8976514. DOI: 10.2147/DMSO.S308620.


Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes.

Sherr J, Xing D, Ruedy K, Beck R, Kollman C, Buckingham B Diabetes Care. 2013; 36(6):1470-6.

PMID: 23288858 PMC: 3661789. DOI: 10.2337/dc12-1697.


Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D.

Berry D, Vimaleswaran K, Whittaker J, Hingorani A, Hypponen E PLoS One. 2012; 7(5):e37465.

PMID: 22629401 PMC: 3357436. DOI: 10.1371/journal.pone.0037465.


A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.

Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M Diabetes Care. 2012; 35(2):204-10.

PMID: 22210571 PMC: 3263860. DOI: 10.2337/dc11-1746.